FIELD: medicine, particularly, oncology. SUBSTANCE: method includes introduction of cyclophosphamide into pleural cavity once in 7 or 10 or 14 days individually in optimally tolerable dose of 200-400 mg during 6-17 months and longer up to full stabilization of process. EFFECT: increased duration of life in incurable patients with carcinoma of mammary glands with lymphgland and other organ metastases. 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING TUMOR PLEURITIS | 2002 |
|
RU2225228C2 |
METHOD FOR TREATING BILATERAL TUMOR PLEURITIS | 2002 |
|
RU2225231C1 |
BREAST CANCER CHEMOTHERAPY PROCEDURE | 2008 |
|
RU2372917C1 |
METHOD FOR COMBINED TREATMENT OF MALIGNANT TUMOR INJURIES OF PLEURA, ACCOMPANIED BY EXUDATIVE PLEURISY | 2005 |
|
RU2289352C1 |
INTEGRATED TREATMENT OF MALIGNANT TUMOUR PLEURA INVOLVEMENT ACCOMPANIED WITH EXUDATIVE PLEURISY | 2008 |
|
RU2358775C1 |
METHOD FOR PHOTODYNAMIC THERAPY OF PATIENTS WITH METASTATIC TUMOURAL PLEURITIS | 2013 |
|
RU2514107C1 |
METHOD FOR TREATING THE CASES OF NON-OPERABLE CANCER METASTASIZING INTO LYMPH NODES | 2002 |
|
RU2218186C2 |
METHOD OF VIDEO-ASSISTED MEDIASTINAL LYMPHADENECTOMY | 2008 |
|
RU2381753C1 |
METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438659C1 |
METHOD FOR TREATING THE CASES OF LUNG CARCINOMA | 2003 |
|
RU2245112C1 |
Authors
Dates
1999-12-10—Published
1997-08-01—Filed